Literature DB >> 9474019

Rapid, convenient radioimmunoassay of estrone sulfate.

G N Ranadive1, J S Mistry, K Damodaran, M J Khosravi, A Diamandi, T Gimpel, V D Castracane, S Patel, F Z Stanczyk.   

Abstract

We developed a specific, simple, and rapid RIA for the direct quantification of estrone sulfate (E1S) and established its performance characteristics. The assay has a dynamic range of 0.05-90 micrograms/L with a detection limit of 0.009 microgram/L. Intraassay CVs were 9.2%, 4.5%, and 4.6% at 0.35, 9.0, and 60 micrograms/L, respectively. Interassay CVs were 8.8%, 5.1%, and 5.5% at 0.076, 0.5, and 12 micrograms/L, respectively. Linearity of dilution studies showed values of 80-105% of expected, and recovery of E1S added to serum samples ranged from 82% to 102%. Cross-reactivities with structurally related estrogens were < 5%. When compared with a conventional assay (involving hydrolysis of E1S and indirect measurement of estrone), the present RIA showed excellent correlation (r = 0.99, slope = 1.54, Sy/x = 2.14, n = 71). Mean E1S concentrations measured with this RIA for normal men (n = 20) and women in follicular (n = 20) and luteal (n = 25) phases of their menstrual cycle were 0.96, 0.96, and 1.74 microgram/L, respectively. Mean E1S concentrations for oral contraceptive users (n = 20) and postmenopausal women without hormone replacement therapy (n = 21) or on hormone replacement therapy (n = 22) were 0.74, 0.13, and 2.56 micrograms/L, respectively. Serum concentrations of E1S in pregnant women in their first (n = 14), second (n = 17), and third (n = 15) trimesters were 20, 66, and 105 micrograms/L, respectively. Availability of this simple RIA should provide a useful tool for the assessment of estrogen status in women.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9474019

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.

Authors:  Christy G Woolcott; Yurii B Shvetsov; Frank Z Stanczyk; Lynne R Wilkens; Kami K White; Christian Caberto; Brian E Henderson; Loïc Le Marchand; Laurence N Kolonel; Marc T Goodman
Journal:  Endocr Relat Cancer       Date:  2010-02-18       Impact factor: 5.678

2.  Oat5 and NaDC1 protein abundance in kidney and urine after renal ischemic reperfusion injury.

Authors:  Gisela Di Giusto; Naohiko Anzai; Hitoshi Endou; Adriana M Torres
Journal:  J Histochem Cytochem       Date:  2008-09-15       Impact factor: 2.479

3.  Serum Levels of Androgens, Estrogens, and Sex Hormone Binding Globulin and Risk of Primary Gastric Cancer in Chinese Men: A Nested Case-Control Study.

Authors:  Zhikai Zhu; Yingxi Chen; Jiansong Ren; Sanford M Dawsey; Jian Yin; Neal D Freedman; Jin-Hu Fan; Philip R Taylor; Yuanli Liu; You-Lin Qiao; Christian C Abnet
Journal:  Cancer Prev Res (Phila)       Date:  2021-03-25

4.  Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.

Authors:  Xia Ren; Xuan Wu; Stephen G Hillier; K Scott Fegan; Hilary O D Critchley; J Ian Mason; Sana Sarvi; Christopher R Harlow
Journal:  J Steroid Biochem Mol Biol       Date:  2015-03-24       Impact factor: 4.292

5.  Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women.

Authors:  Rachael Z Stolzenberg-Solomon; Roni T Falk; Frank Stanczyk; Robert N Hoover; Lawrence J Appel; Jamy D Ard; Bryan C Batch; Janelle Coughlin; Xu Han; Lillian F Lien; Christina M Pinkston; Laura P Svetkey; Hormuzd A Katki
Journal:  Breast Cancer Res       Date:  2012-10-31       Impact factor: 6.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.